1. Home
  2. MDGL vs BWA Comparison

MDGL vs BWA Comparison

Compare MDGL & BWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • BWA
  • Stock Information
  • Founded
  • MDGL 2011
  • BWA 1987
  • Country
  • MDGL United States
  • BWA United States
  • Employees
  • MDGL N/A
  • BWA N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • BWA Auto Parts:O.E.M.
  • Sector
  • MDGL Health Care
  • BWA Consumer Discretionary
  • Exchange
  • MDGL Nasdaq
  • BWA Nasdaq
  • Market Cap
  • MDGL 6.8B
  • BWA 6.3B
  • IPO Year
  • MDGL N/A
  • BWA 1993
  • Fundamental
  • Price
  • MDGL $282.86
  • BWA $32.91
  • Analyst Decision
  • MDGL Strong Buy
  • BWA Buy
  • Analyst Count
  • MDGL 10
  • BWA 14
  • Target Price
  • MDGL $420.63
  • BWA $38.08
  • AVG Volume (30 Days)
  • MDGL 382.7K
  • BWA 2.2M
  • Earning Date
  • MDGL 05-01-2025
  • BWA 05-07-2025
  • Dividend Yield
  • MDGL N/A
  • BWA 1.34%
  • EPS Growth
  • MDGL N/A
  • BWA N/A
  • EPS
  • MDGL N/A
  • BWA 1.30
  • Revenue
  • MDGL $317,383,000.00
  • BWA $14,006,000,000.00
  • Revenue This Year
  • MDGL $264.55
  • BWA N/A
  • Revenue Next Year
  • MDGL $67.21
  • BWA $3.51
  • P/E Ratio
  • MDGL N/A
  • BWA $25.29
  • Revenue Growth
  • MDGL N/A
  • BWA N/A
  • 52 Week Low
  • MDGL $200.08
  • BWA $24.40
  • 52 Week High
  • MDGL $377.46
  • BWA $38.23
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 35.76
  • BWA 72.94
  • Support Level
  • MDGL $287.46
  • BWA $28.92
  • Resistance Level
  • MDGL $307.54
  • BWA $33.40
  • Average True Range (ATR)
  • MDGL 16.58
  • BWA 0.70
  • MACD
  • MDGL -2.70
  • BWA 0.55
  • Stochastic Oscillator
  • MDGL 3.19
  • BWA 90.81

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About BWA BorgWarner Inc.

BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2023, 25% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.

Share on Social Networks: